|
|
|
Insider
Information: |
Afeyan Noubar |
Relationship: |
Director, 10% Owner |
City: |
Lexington |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
20 |
|
Direct
Shares |
7,980,025 |
|
Indirect Shares
|
111,880,829 |
|
|
Direct
Value |
$14,010,630 |
|
|
Indirect Value
|
$98,146,267 |
|
|
Total
Shares |
119,860,854 |
|
|
Total
Value |
$112,156,897 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
3
|
0
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
2
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
-42.1%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Color Kinetics Inc |
CLRK |
Director |
2005-10-03 |
83,062 |
2005-10-03 |
12,000 |
Premium* |
|
Agenus Inc |
AGEN |
Director |
2006-12-14 |
0 |
2006-12-14 |
0 |
Premium* |
|
Helicos Biosciences Corp |
HLCSQ |
Director, 10% Owner |
2009-09-18 |
0 |
2009-09-18 |
12,192,640 |
Premium* |
|
Receptos, Inc. |
RCPT |
10% Owner |
2013-11-18 |
1,693,551 |
|
0 |
Premium* |
|
DNIB Upwind Inc |
BIND |
Director, 10% Owner |
2013-09-25 |
0 |
2013-09-25 |
1,562,616 |
Premium* |
|
Bg Medicine, Inc. |
BGMD |
Director, 10% Owner |
2015-12-09 |
0 |
2015-12-09 |
1,286,274 |
Premium* |
|
Editas Medicine, Inc. |
EDIT |
10% Owner |
2016-02-08 |
3,964,256 |
2016-02-08 |
991,060 |
Premium* |
|
Cartesian Therapeutics, Inc |
RNAC |
10% Owner |
2016-06-27 |
0 |
2016-06-27 |
1,651,862 |
Premium* |
|
Kaleido Biosciences, Inc. |
KLDO |
10% Owner |
|
0 |
2021-02-08 |
14,907,627 |
Premium* |
|
Transmedics Group, Inc. |
TMDX |
10% Owner |
|
0 |
2019-10-29 |
120,595 |
Premium* |
|
Seres Therapeutics, Inc. |
MCRB |
10% Owner |
2019-06-18 |
15,141 |
2022-07-05 |
17,617,352 |
Premium* |
|
Moderna, Inc. |
MRNA |
|
2024-07-31 |
2,224,015 |
2024-07-31 |
4,632,149 |
Premium* |
|
Axcella Health Inc. |
AXLA |
10% Owner |
2020-05-18 |
0 |
2022-10-13 |
8,850,296 |
Premium* |
|
Evelo Biosciences Inc |
EVLO |
|
2020-06-29 |
0 |
2023-07-11 |
4,977,588 |
Premium* |
|
Codiak Biosciences, Inc. |
CDAK |
10% Owner |
|
0 |
2022-09-15 |
1,674,869 |
Premium* |
|
Foghorn Therapeutics Inc. |
FHTX |
10% Owner |
2020-10-27 |
0 |
2020-10-27 |
1,851,801 |
Premium* |
|
Sigilon Therapeutics, Inc. |
SGTX |
10% Owner |
2020-12-08 |
0 |
2023-08-11 |
0 |
Premium* |
|
Sana Biotechnology, Inc. |
SANA |
10% Owner |
2021-02-08 |
0 |
2023-09-13 |
581,695 |
Premium* |
|
Rubius Therapeutics, Inc. |
RUBY |
Director, 10% Owner |
2021-03-19 |
0 |
2021-03-19 |
17,253,519 |
Premium* |
|
Omega Therapeutics, Inc. |
OMGA |
Director, 10% Owner |
2021-08-03 |
0 |
2023-02-27 |
21,716,886 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
155 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 5 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
MRNA |
Moderna, Inc. |
|
|
2023-06-21 |
4 |
AS |
$121.60 |
$1,829,227 |
D/D |
(15,000) |
2,127,209 |
0 |
- |
|
MRNA |
Moderna, Inc. |
Director |
|
2022-11-16 |
4 |
AS |
$184.25 |
$1,842,500 |
D/D |
(10,000) |
2,327,209 |
0 |
- |
|
MRNA |
Moderna, Inc. |
|
|
2024-07-17 |
4 |
AS |
$120.86 |
$1,842,651 |
D/D |
(15,000) |
2,254,015 |
0 |
- |
|
MRNA |
Moderna, Inc. |
Director |
|
2023-07-05 |
4 |
AS |
$123.46 |
$1,870,933 |
D/D |
(15,000) |
2,097,209 |
0 |
- |
|
MRNA |
Moderna, Inc. |
|
|
2023-07-19 |
4 |
AS |
$124.14 |
$1,882,152 |
D/D |
(15,000) |
2,067,209 |
0 |
- |
|
MRNA |
Moderna, Inc. |
Director |
|
2023-01-11 |
4 |
AS |
$188.57 |
$1,885,700 |
D/D |
(10,000) |
2,257,209 |
0 |
- |
|
MRNA |
Moderna, Inc. |
|
|
2023-07-12 |
4 |
AS |
$124.59 |
$1,887,081 |
D/D |
(15,000) |
2,082,209 |
0 |
- |
|
MRNA |
Moderna, Inc. |
Director |
|
2023-06-07 |
4 |
AS |
$125.76 |
$1,888,601 |
D/D |
(15,000) |
2,157,209 |
0 |
- |
|
MRNA |
Moderna, Inc. |
Director |
|
2023-06-14 |
4 |
AS |
$125.43 |
$1,892,627 |
D/D |
(15,000) |
2,142,209 |
0 |
- |
|
MRNA |
Moderna, Inc. |
|
|
2024-06-26 |
4 |
AS |
$122.69 |
$1,908,293 |
D/D |
(15,000) |
2,284,015 |
0 |
- |
|
MRNA |
Moderna, Inc. |
|
|
2024-05-15 |
4 |
AS |
$125.53 |
$1,909,863 |
D/D |
(15,000) |
1,996,931 |
0 |
- |
|
MRNA |
Moderna, Inc. |
Director |
|
2023-05-31 |
4 |
AS |
$125.69 |
$1,910,322 |
D/D |
(15,000) |
2,172,209 |
0 |
- |
|
MRNA |
Moderna, Inc. |
Director |
|
2023-01-25 |
4 |
AS |
$194.33 |
$1,943,300 |
D/D |
(10,000) |
2,237,209 |
0 |
- |
|
EVLO |
Evelo Biosciences Inc |
10% Owner |
|
2021-02-02 |
4 |
B |
$15.00 |
$1,950,000 |
I/I |
130,000 |
4,125,461 |
1.5 |
- |
|
MRNA |
Moderna, Inc. |
Director |
|
2022-12-14 |
4 |
AS |
$195.00 |
$1,950,000 |
D/D |
(10,000) |
2,287,209 |
0 |
- |
|
MRNA |
Moderna, Inc. |
Director |
|
2023-01-18 |
4 |
AS |
$200.20 |
$2,002,000 |
D/D |
(10,000) |
2,247,209 |
0 |
- |
|
MRNA |
Moderna, Inc. |
|
|
2024-06-18 |
4 |
AS |
$132.22 |
$2,003,561 |
D/D |
(15,000) |
2,299,015 |
0 |
- |
|
MRNA |
Moderna, Inc. |
Director |
|
2022-12-21 |
4 |
AS |
$201.70 |
$2,017,000 |
D/D |
(10,000) |
2,277,209 |
0 |
- |
|
MRNA |
Moderna, Inc. |
|
|
2024-06-12 |
4 |
AS |
$142.97 |
$2,208,071 |
D/D |
(15,000) |
2,314,015 |
0 |
- |
|
MRNA |
Moderna, Inc. |
|
|
2024-06-05 |
4 |
AS |
$145.91 |
$2,268,804 |
D/D |
(15,000) |
1,946,931 |
0 |
- |
|
SANA |
Sana Biotechnology, Inc. |
10% Owner |
|
2023-05-24 |
4 |
S |
$6.57 |
$2,283,836 |
I/I |
(347,870) |
1,447,791 |
0 |
- |
|
MRNA |
Moderna, Inc. |
|
|
2024-05-22 |
4 |
AS |
$142.95 |
$2,363,556 |
D/D |
(15,000) |
1,981,931 |
0 |
- |
|
FHTX |
Foghorn Therapeutics Inc. |
10% Owner |
|
2020-10-27 |
4 |
B |
$16.00 |
$2,400,000 |
I/I |
150,000 |
1,851,801 |
1.5 |
- |
|
KLDO |
Kaleido Biosciences, Inc. |
10% Owner |
|
2021-02-08 |
4 |
B |
$11.50 |
$2,472,500 |
I/I |
215,000 |
738,333 |
1.5 |
- |
|
CDAK |
Codiak Biosciences, Inc. |
10% Owner |
|
2020-10-16 |
4 |
B |
$15.00 |
$2,475,000 |
I/I |
165,000 |
1,143,177 |
1.5 |
- |
|
155 Records found
|
|
Page 5 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|